The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Salmoporc lyophilisate for oral suspension for pigs

. Lyophilisate for oral suspension

Ceva Santé AnimaleVPA10815/064/002

Main Information

Trade NameSalmoporc lyophilisate for oral suspension for pigs
Active SubstancesSalmonella typhimurium mutant, strain 421/125
Dosage FormLyophilisate for oral suspension
Licence HolderCeva Santé Animale
Licence NumberVPA10815/064/002

Group Information

ATC CodeQI09AE02 salmonella
Therapeutic ClassImmunological - Live Vaccine


Licence Issued18/04/2019
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back